Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953–2015: A population-based prospective cohort study
Øivind Kvammen, Tor Åge Myklebust, Arne Solberg, et al.
PLoS ONE (2019) Vol. 14, Iss. 12, pp. e0225942-e0225942
Open Access | Times Cited: 15

Showing 15 citing articles:

Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST)
Andreas Hiester, Yue Che, Achim Lusch, et al.
European Urology (2022) Vol. 84, Iss. 1, pp. 25-31
Closed Access | Times Cited: 56
Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS)
Axel Heidenreich, Pia Paffenholz, Florian Hartmann, et al.
European Urology Oncology (2023) Vol. 7, Iss. 1, pp. 122-127
Closed Access | Times Cited: 30
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort
Ragnhild Hellesnes, Tor Åge Myklebust, Sophie D. Fosså, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 32, pp. 3561-3573
Open Access | Times Cited: 37
Testicular cancer in 2023: Current status and recent progress
Deaglan Joseph McHugh, Jack P. Gleeson, Darren R. Feldman
CA A Cancer Journal for Clinicians (2023) Vol. 74, Iss. 2, pp. 167-186
Open Access | Times Cited: 13
Testicular tumors: Diagnosis and endocrine aspects
Ewa Rajpert-De Meyts
Elsevier eBooks (2025)
Closed Access
Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor
Eric Umbreit, Bilal A. Siddiqui, Michael J. Hwang, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3755-3755
Open Access | Times Cited: 26
Long-term toxicity of the treatment for germ cell-cancer. A review
Pablo Maroto, Geòrgia Anguera, Cristina Martîn
Critical Reviews in Oncology/Hematology (2017) Vol. 121, pp. 62-67
Closed Access | Times Cited: 24
Prognostic factors in patients with clinical stage I nonseminoma—beyond lymphovascular invasion: a systematic review
Friedemann Zengerling, Dirk Beyersdorff, Jonas Busch, et al.
World Journal of Urology (2022) Vol. 40, Iss. 12, pp. 2879-2887
Open Access | Times Cited: 8
Late toxicities and recurrences in patients with clinical stage I non-seminomatous germ cell tumours after 1 cycle of adjuvant bleomycin, etoposide and cisplatin versus primary retroperitoneal lymph node dissection – A 13-year follow-up analysis of a phase III trial cohort
Andreas Hiester, Anna Fingerhut, Günter Niegisch, et al.
European Journal of Cancer (2021) Vol. 155, pp. 64-72
Closed Access | Times Cited: 11
An exploration of testicular cancer survivors’ experience of ejaculatory dysfunction following retroperitoneal lymph node dissection—a sub-study of the PREPARE clinical trial
Ciara Conduit, Amanda D. Hutchinson, Michael Leonard, et al.
Journal of Cancer Survivorship (2023)
Closed Access | Times Cited: 4
Long Term Side Effects of Testicular Cancer and Treatment (Observational Study of Mortality and Morbidity in Testicular Cancer Survivors)
Manoranjan Khan, Patrice Kearney Sheehan, Ashley Bazin, et al.
(2024)
Open Access | Times Cited: 1
Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort
Annalisa Trama, Alice Bernasconi, Laura Botta, et al.
Pediatric Blood & Cancer (2022) Vol. 69, Iss. 12
Open Access | Times Cited: 3
Seminom im klinischen Stadium IIA/B – machen oder nicht machen: welchen Stellenwert hat die retroperitoneale Lymphadenektomie?
Axel Heidenreich, Felix Seelemeyer, Ruben Gößmann, et al.
Aktuelle Urologie (2024)
Closed Access
Die primäre retroperitoneale Lymphadenektomie beim testikulären Keimzelltumor im klinischen Stadium IIA/B – Renaissance einer etablierten Therapie?
Julian Heidenreich, Ruben Gößmann, Felix Seelemeyer, et al.
Deleted Journal (2024)
Closed Access
Late side effects of testicular cancer and treatment: a comprehensive review
Muhammad Raheel Khan, Patrice Kearney Sheehan, Ashley Bazin, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Page 1

Scroll to top